Pain management is one of the greatest challenges facing our healthcare system right now. We’ve witnessed tremendous growth in utilization trends stemming from the ‘perfect-storm’ effect playing out in this industry over the past several years, earning it the title of ‘last, wild, wild west of healthcare,’ as many like to call it. The unique […]
When Massachusetts-based Neurometrix (NURO) created a wearable device for pain management for patients suffering from diabetic peripheral neuropathy (DPN), founder and CEO Shai Gozani knew usability was key. More than a quarter of diabetic patients must cope with DPN, a burning, stabbing, acute pain, usually in the legs and feet, Gozani said. The Sensus, NURO’s nerve-stimulator […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Neuros Medical, a Cleveland-based medical device company, received an FDA investigational device exemption approval to begin a clinical study on its technology for intractable limb pain management for amputees. According to the company website, the Altius System High Frequency Nerve Block technology “consists of an electrode (also known as a lead) placed around a peripheral […]
A year ago, Bernard Belisle was in a bad way. Pain throbbed in his legs all day, every day, and he was angry and irritable much of the time. Then, he enrolled in a novel study on preventing depression in older adults at the University of Pittsb...
Cleveland-based medical device company SPR Therapeutics has upped its series A yet again and raised an additional $2.8 million, which brings its total to $5 million from NDI Healthcare Fund, Public Square Partners and individual investors. CEO Maria Bennett said the funding will help the company commercialize its peripheral nerve stimulation technology platform. The […]
Certified Registered Nurse Anesthetists have administered opiate and steroid injections, ultrasound medical imaging, and refills for implantable anesthetic pumps. Medicare may stop paying them for providing these services to patients.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.